Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition

Article

Mylan proposed to acquire Perrigo for $205 per share in a cash-and-stock transaction on April 6, 2015.

PRESS RELEASE

POTTERS BAR, England, April 13, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that it has provided Perrigo Company plc (NYSE: PRGO; TASE) with notice of its filing today of the premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with the U.S. Federal Trade Commission and the U.S. Department of Justice Antitrust Division regarding its proposed acquisition of Perrigo, as required by the HSR Act. Mylan proposed to acquire Perrigo for $205 per share in a cash-and-stock transaction on April 6, 2015.

Mylan Executive Chairman Robert J. Coury stated, "As we continue to await for Perrigo's Board of Directors' deliberations to be complete, today's filing represents another important step in our ongoing determination to make this compelling proposed combination a reality. We are eager to continue our prior discussions with Perrigo as soon as possible and to mutually agree on the way forward."

Related Videos
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Pharmacist holding medicine box and capsule pack in pharmacy drugstore. -- Image credit: I Viewfinder | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.